You've just added:

Our Impact

How we're advancing cures globally

177

Medicines in the making

64

Institutions supported

36

Companies launched

19

Medicines in the clinic

13

Licenses to pharma

What sets us apart

In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.

Learn More

Making discoveries partner-ready

Our pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.

See all discoveries

The Latest

See All News
AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

Press Releases

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC)

Continue Reading
Unveiling the Oxygen and Nitric Oxide Exercise Monitor

Podcasts

Unveiling the Oxygen and Nitric Oxide Exercise Monitor

A Conversation with Jonathan S. Stamler, MD, President of Harrington Discovery Institute

Continue Reading
Takeda Licenses LSU Health New Orleans Technology for Potential Rare Neurological Disorders

Press Releases

Takeda Licenses LSU Health New Orleans Technology for Potential Rare Neurological Disorders

New Orleans, LA – LSU Health New Orleans today announced that has exercised its option to receive an exclusive license to...

Continue Reading

Sign Up

Become a part of our community and receive periodic communications with news and updates, as well as notifications of grant funding opportunities.